Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of lncrna-266 in the preparation of drugs for inducing brown adipocyte differentiation

A technology of lncrna-266, 1. lncrna-266, applied in the application of drugs to promote the energy metabolism of the body, in the field of preparation and induction of brown adipocyte differentiation, which can solve problems such as developmental defects and various diseases

Active Publication Date: 2021-09-17
NANTONG UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, recent studies have found that many lncRNAs have very important physiological functions, and their abnormal levels can lead to developmental defects and the occurrence and development of various diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of lncrna-266 in the preparation of drugs for inducing brown adipocyte differentiation
  • Application of lncrna-266 in the preparation of drugs for inducing brown adipocyte differentiation
  • Application of lncrna-266 in the preparation of drugs for inducing brown adipocyte differentiation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1 LncRNA-266 overexpression and interference virus construction

[0025] Preparation of overexpression virus: In this study, the overexpression virus was constructed using Invitrogen’s Gateway series kits. Firstly, PCR is used to amplify the complete sequence of LncRNA, and then it is connected into the intermediate vector pENTR3C-EntryVector and then sent to the company for sequencing. The sequenced correct vector is connected into the target vector (pAd-CMV-DEST Vector) by recombination method (LR). , after the sequencing detection was correct, the positive plasmids were extracted and single-cut by the endonuclease Pac I, and then transfected into 293A cells with Lipofectamine 2000 liposome from Invitrogen Company. Observe the formation of viral plaques for about a week. After most of the viral plaques appear, collect 293A cells and perform repeated freezing and thawing at -80°C and 37°C to break the cells, and collect the supernatant by centrifugation to obta...

Embodiment 2

[0027] Example 2 LncRNA-266 induces differentiation of preadipocytes

[0028] Primary preadipocyte culture: 8-week-old male C57BL / 6J mice, take groin white adipose tissue in a centrifuge tube, collagenase digestion solution (collagenase 1mg / ml dissolved in separation buffer ----- including 0.123 M NaCl, 5mM KCl, 1.3mM CaCl 2 , 5nM glucose, 100mM Hepes, 4% BSA) 37°C water bath for 30min, shake once every 5min, filter with 100μm nylon mesh, centrifuge at 200g×5min. Remove the supernatant, add 2ml separation buffer to fully suspend the cells, and centrifuge at 200g×5min. Remove the supernatant, add 2ml of culture medium (DMEM high glucose medium, 20% fetal bovine serum, 20mM Hepes, 100U / ml penicillin / streptomycin) to fully suspend the cells, plant them in a culture dish, place at 37°C, 5% CO 2 cultured in an incubator.

[0029] Directed differentiation of brown adipocytes: In order to detect the transformation of lncRNA-266 from preadipocytes to brown adipocytes, before addin...

Embodiment 3

[0039] Example 3 Effect of LncRNA-266 on Glucose Metabolism in Type Ⅱ Diabetic Mice

[0040] 6-week-old male C57BL / 6J mice were fed with a high-fat diet (Research Diet, 45% calories from fat) for 90 days to induce obesity model mice (ie, type II diabetes model mice). The adenovirus expressing LncRNA-266 (Ad-LncRNA-266) was directly injected into the inguinal beige adipose tissue of type Ⅱ diabetes model mice, and the dose used was to inject 40 μl of virus (1×10 12 PFU). Mice in the control group were injected with the same dose of control virus (Ad-LacZ). Three weeks after virus injection, various physiological indicators were detected.

[0041] After the mice were fasted for 12 hours, blood was taken from the tail vein, and the blood glucose level was quantitatively detected with a blood glucose meter (Bayer, Mishawaka, IN). The results are as follows: image 3 shown. image 3 The results showed that LncRNA-266 treatment could reduce blood glucose levels in type 2 diabete...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the medical use of a long-chain non-coding RNA (LncRNA-266), that is, the application of LncRNA-266 in the preparation of drugs for inducing differentiation of brown adipocytes, which can promote energy consumption of the body and resist obesity. The present invention treats obese mice with LncRNA-266, and the results show that LncRNA-266 can promote the differentiation of beige adipocytes into brown adipocytes in obese mice, consume body energy, and thereby inhibit weight gain. The present invention further found that LncRNA-266 can reduce blood sugar level and improve insulin sensitivity in obese mice.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of LncRNA-266 in the preparation of medicines for inducing brown fat cell differentiation and promoting body energy metabolism. Background technique [0002] Obesity is a physiological state of energy metabolism disorder in the body, which is characterized by a large amount of excess energy accumulated in the body in the form of fat. Obesity is a serious threat to human health, it can induce a variety of metabolic diseases, such as fatty liver, type 2 diabetes, cardiovascular disease, certain types of cancer, etc. There are two main types of adipose tissue in the body, namely white adipose tissue and brown adipose tissue. In terms of energy metabolism, white adipocytes contain a large amount of triglycerides, so white adipose tissue is mainly used as an organ for storing body energy; in contrast, brown adipocytes contain a large number of mitochondria and high...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7105A61P3/04A61P3/10
CPCA61K31/7105A61P3/04A61P3/10
Inventor 孙诚汤欣马谨瑜刘晓宇
Owner NANTONG UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com